4,239
Views
3
CrossRef citations to date
0
Altmetric
Research Paper

Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer

, , , &
Pages 695-705 | Received 10 Nov 2017, Accepted 03 Mar 2018, Published online: 08 May 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Mengxia Liang, Yiwen Liu, Zheyuan Zhang, Haijun Yang, Ningtao Dai, Ning Zhang, Wei Sun, Yibo Guo, Jinyu Kong, Xiaopeng Wang, Min Wang & Fuyou Zhou. (2022) Fusobacterium nucleatum induces MDSCs enrichment via activation the NLRP3 inflammosome in ESCC cells, leading to cisplatin resistance. Annals of Medicine 54:1, pages 989-1003.
Read now
Xuemei Xie, Jangsoon Lee, Toshiaki Iwase, Megumi Kai & Naoto T Ueno. (2022) Emerging drug targets for triple-negative breast cancer: a guided tour of the preclinical landscape. Expert Opinion on Therapeutic Targets 26:5, pages 405-425.
Read now
Jeong Hun Kim, Won Suk Lee, Hye Jin Lee, Hannah Yang, Seung Joon Lee, So Jung Kong, Soyeon Je, Hyun-Jin Yang, Jongsun Jung, Jaekyung Cheon, Beodeul Kang, Hong Jae Chon & Chan Kim. (2021) Deep learning model enables the discovery of a novel immunotherapeutic agent regulating the kynurenine pathway. OncoImmunology 10:1.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.